20768-11-0

Basic information

• Product Name: LACTODIFUCOTETRAOSE
• Synonyms: 3,2'-DIFUCOSYLLACTOSE;ALPHA-L-FUC-[1->2]-BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-D-GLC;LACTODIFUCOTETRAOSE;LACTODIFUCOTETRAOSE, HUMAN MILK;LDFT;FUC-ALPHA1,2GAL-BETA1,4(FUC-ALPHA1,3)GLC;DFL;LACTODIFUCOTETRAOSE FROM HUMAN MILK
• CAS NO: 20768-11-0
• Molecular Formula: C24H42O19
• Molecular Weight: 634.58
• Mol File: 20768-11-0.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 1028.2 °C at 760 mmHg
• Flash Point: 335.1 °C
• Appearance: /
• Density: 1.68 g/cm³
• Storage Temp.: −20°C
• PKA: 12.20±0.20(Predicted)
• CAS DataBase Reference: LACTODIFUCOTETRAOSE(CAS DataBase Reference)
• NIST Chemistry Reference: LACTODIFUCOTETRAOSE(20768-11-0)
• EPA Substance Registry System: LACTODIFUCOTETRAOSE(20768-11-0)

Safety Data

• Hazard Codes: B
• WGK Germany: 3
• F: 10-21
• Hazardous Substances Data: 20768-11-0(Hazardous Substances Data)

Usage

General Description

Lactodifucotetraose is a complex oligosaccharide composed of four sugar units - two molecules of lactose and two molecules of fucose. It is a prebiotic compound that has been shown to have potential health benefits. Lactodifucotetraose has been found to selectively promote the growth of beneficial bacteria in the gut, such as Bifidobacteria, while inhibiting the growth of harmful bacteria. This selective stimulation of beneficial bacteria can contribute to improved gut health and overall immune function. Lactodifucotetraose is also being studied for its potential use in infant formula to mimic the prebiotic benefits of human breast milk. Overall, research on lactodifucotetraose suggests that it has promising applications in promoting gut health and overall well-being.